CTSL and COVID-19: Some potential biological targets include the inhibition of host proteases like cathepsin L, the targeting of viral RNA-dependent RNA polymerase to impede viral genome replication, and the modulation of host immune responses to strengthen antiviral defense and minimize the harmful effects of inflammation caused by COVID-19.